Natura opens a new innovation center in New York

The Brazilian multinational of cosmetics, Natura, inaugurated an innovation center in New York las February 3rd. The initiative aims to identify trends, opportunities and new concepts connecting cosmetics, design, fashion and technology to develop innovative prototypes. Continuar lendo

Share Button

Innovative research with Matico wins the award promoted by Natura

The ingredient used as a natural repellent to dengue and malaria mosquito wins Natura’s Award on Vegetal Ingredients. Continuar lendo

Share Button

Wenovate is selected to perform the InovAtiva Brazil

Wenovate, company focused on the practice of Open Innovation, was selected by Ministry of Development, Industry and Foreign Trade as responsible for revision, improvement, expansion and operation of InovAtiva Brazil program in 2014.  Continuar lendo

Share Button

Gripen NG is selected after a campaign focused on innovation

Wenovate welcomes Saab and CISB for having bet on open innovation as strategy to mount the selected order by the Brazilian government. Brazilian researchers are being called to make part of this history. Registrations are now open for postgraduate scholarships in Sweden. Continuar lendo

Share Button

Natura reinforces its commitment to Innovation

The company has received funding of R$ 205 million from FINEP, for investment in innovation, and launches Notice to creation of Center for Applied Research in Wellness and Human Behavior in partnership with FAPESP.

Share Button

Cases of innovation to the 14th Anpei conference can be submitted until January 30

The National Association for Research and Development of Innovative Companies (Anpei) promotes, on 28 and 29 April 2014, the 14th edition of Anpei Conference on Technological Innovation in São Paulo.

Share Button

EMS gives first steps outside the country

EMS, largest pharmaceutical group in national capital, officiated investment of US$ 200 millions in United States, that will be done by Brace Pharma, subsidiary created by the Brazilian company in Maryland (USA), controlled by the entrepeneur Carlos Sanchez, to develop innovative medicines.

Share Button